Marinol Articles
Watson buy of Arrow requires product divestments, says USA’s FTC
4 December 2009
Profit plummets 55% for Solvay in recession
15 May 2009
Major US federal switch on medicinal marijuana
23 March 2009
Cannabinoid medicines may be addictive; study
9 February 2009
Solvay's 9-month profit down 34% on Fortis
10 November 2008
Solvay's first-half 2008 profit declines 15%
11 August 2008
California OKs medical marijuana dispensers
14 February 2008
Cannabinoid market forecast at over $700 million
26 March 2007
Solvay's 2005 revenue reaches 8.5 B euros
27 February 2006
Use of cannabis in MS not clear, say trial data
17 November 2003
Pretax profits down at Belgium's Solvay
18 February 2002
Marinol Reclassified As Schedule III Drug?
18 November 1998
Unimed Pharmaceuticals' Marinol "May Be Effective" In Alzheimers
2 December 1996
California Marijuana Initiative Passes
18 November 1996
Unimed's Dronabinol In Alzheimer's Disease
5 August 1996
Health Insurers In Massachusetts To Pay For AIDS Drugs
22 April 1996
Unimed: Marinol launch
23 October 1995
Unimed Licenses Two Testosterone Products
21 August 1995
NEW FORMULATION OF B-MS' MEGACE
27 September 1993
ANABOLIC STEROIDS FOR AIDS WASTING?
21 June 1993
MARINOL APPROVED FOR AIDS ANOREXIA
18 January 1993
Showing 1-25 of 25 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
